Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults - Summary - MDSpire
Advertisement
Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults
To describe the initial triage processes and hospitalization outcomes of adolescents and young adults (AYA) with confirmed invasive meningococcal disease (IMD) and identify associations between presenting clinical characteristics and intensive care unit (ICU) admissions.
Key Findings:
In 2023, Australia reported 143 cases of IMD, marking a 14% increase from 2022.
Serogroup B was responsible for 84% of IMD cases.
Common delays in diagnosis and treatment were attributed to nonspecific early symptoms.
The case fatality rate for adolescents and young adults ranges from 10 to 15%.
Up to 61% of young adult survivors experienced lasting sequelae.
Interpretation:
The study underscores the urgent need for improved recognition and timely intervention for IMD in AYAs to reduce complications and enhance clinical outcomes, potentially through targeted training for healthcare providers.
Limitations:
The retrospective design may limit the comprehensiveness of data, potentially affecting the reliability of findings.
Focusing on a specific age group may not represent the entire population affected by IMD, limiting generalizability.
Conclusion:
Enhanced awareness and prompt clinical assessment are essential to mitigate the risks associated with late diagnosis of IMD in adolescents and young adults, emphasizing the need for training and resources in emergency settings.
by Mark McMillan, Hassen Mohammed, Jim Buttery, Margaret Angliss, Belinda Barton, Christopher C. Blyth, Suja M. Mathew, Morgyn S. Warner, Renjy Nelson, Rory Hannah, Naomi Runnegar, Helen Siobhan Marshall
